USE OF IL-1 BETA BINDING ANTIBODIES

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Thuren, Tom,Zalewski, Andrew,Shetzline, Michael

申请号：

AU2018202009

公开号：

AU2018202009A1

申请日:

2018.03.21

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

#$%^&*AU2018202009A120180412.pdf#####ll: sxd Interwoven NRPortbl DCC SXD 16680147 _.docx-21 032018 Abstract The present invention relates to an IL- 10 binding antibody or a functional fragment thereof for use in preventing or reducing risk of experiencing a recurrent cardiovascular (CV) 5 event or a cerebrovascular event in a patient that has suffered of a qualifying CV event.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/